Prediction of HER2 expression in breast cancer patients based on multi-parametric MRI intratumoral and peritumoral radiomics features combined with clinical and imaging indicators
Vorhersage der HER2-Expression bei Brustkrebs anhand multiparametrischer MRT-Radiomics aus intra- und peritumoralen Regionen kombiniert mit klinischen und Bildgebungsmerkmalen
Frontiers in Oncology · 09.06.2025 · 15
DOI: 10.3389/fonc.2025.1531553 ↗Auf einen Blick
Bei 252 Brustkrebspatient:innen sagte ein kombiniertes klinisch-radiomisches Modell den HER2-Status besser voraus als einzelne Radiomics- oder klinische Bildgebungsmodelle.
Fragestellung
Kann der HER2-Status bei Brustkrebs präoperativ mit multiparametrischer MRT-Radiomics aus intra- und peritumoralen Regionen sowie klinischen und Bildgebungsmerkmalen vorhergesagt werden?
Methode
Retrospektive Studie mit 252 Patient:innen; Radiomics aus DCE-MRT, ADC und T2FS; Modellbildung mittels Pearson-Korrelation, rekursiver Merkmalselimination und logistischer Regression; AUC als Leistungsmaß.
Ergebnisse
Das kombinierte klinisch-radiomische Modell erreichte AUCs von 0,923 im Trainings-, 0,915 im Test- und 0,837 im externen Validierungssatz und lag über den Vergleichsmodellen.
Schlussfolgerung der Autor:innen
Das kombinierte Modell aus DCE+T2FS+ADC-Radiomics und klinischen Bildgebungsmerkmalen kann den HER2-Expressionsstatus von Brustkrebs besser vorhersagen.
Kernaussagen
- 252 Patient:innen mit pathologisch gesichertem Brustkrebs
- Kombiniertes Modell: AUC 0,923; 0,915; 0,837
- Besser als reine Radiomics- und klinische Bildgebungsmodelle
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 09.06.2025. Verfasst von Xiaoxiao Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objective
To preoperatively evaluate the HER2 status in breast cancer using multiparametric MRI intratumoral and peritumoral radiomics features combined with clinical and imaging characteristics.
Methods
This retrospective study included 252 patients with pathologically confirmed breast cancer (mean age, 50.1 ± 10.1 years) who underwent breast MRI at our hospital. Among them, 202 patients (70 HER2-positive and 132 HER2-negative) were randomly divided into a training set (n = 141) and testing set (n = 61) in a 7:3 ratio from July 2020 to December 2021. The external validation set consisted of 50 breast cancer cases (20 HER2-positive and 30 HER2-negative) from September 2024 to March 2025. Radiomics features extracted from intratumoral and peritumoral regions of the tumor on axial dynamic contrast-enhanced MRI (DCE-MRI), apparent diffusion coefficient (ADC), and T2-weighted fat-suppressed (T2FS) sequences were subjected to dimensionality reduction and model construction using Pearson correlation coefficients, recursive feature elimination, and logistic regression. Univariate and multivariate logistic regression was used to identify the independent risk factors in clinical, pathological and conventional MRI data for constructing the clinical imaging model. The combined model was built from radiomics and clinical imaging features. The area under the receiver operating characteristic curves (AUCs) were used to evaluate the predictive performance of the models.
Results
There were significant statistical differences between the HER2-positive and HER2-negative groups in terms of PR expression (p=0.041), spiculation sign (p<0.001), and uneven margins (p=0.005). The AUC of radiomics models based on DCE, T2FS, and ADC sequences were 0.742, 0.748, 0.791 respectively in the training set, and 0.776, 0.708, 0.713 respectively in the testing set. The AUC of the combined clinical-radiomics model in the training set, testing set and external validation set was 0.923, 0.915 and 0.837, respectively, which was higher than the intratumoral and peritumoral radiomics model based on DCE+T2FS+ADC sequences (0.854,0.748 and 0.770) and clinical imaging model (0.820,0.789 and 0.709).
Conclusions
The combined model based on DCE+T2FS+ADC intratumoral and peritumoral radiomics integrating with clinical imaging features can better predict the HER2 expression status of breast cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
- Department of Radiology, Binzhou Medical University Hospital, Binzhou, Shandong, China.
Zitieren
APA
Li, X., Fang, J., Wang, F., Zhang, L., Jiang, X., & Mao, X. (2025). Prediction of HER2 expression in breast cancer patients based on multi-parametric MRI intratumoral and peritumoral radiomics features combined with clinical and imaging indicators. Frontiers in Oncology, 15. https://doi.org/10.3389/fonc.2025.1531553
Vancouver
Li X, Fang J, Wang F, Zhang L, Jiang X, Mao X. Prediction of HER2 expression in breast cancer patients based on multi-parametric MRI intratumoral and peritumoral radiomics features combined with clinical and imaging indicators. Frontiers in Oncology. 2025;15. doi:10.3389/fonc.2025.1531553
BibTeX
@article{Li2025,
author = {Li, Xiaoxiao and Fang, Junfang and Wang, Fuqian and Zhang, Lin and Jiang, Xingyue and Mao, Xijin},
title = {Prediction of HER2 expression in breast cancer patients based on multi-parametric MRI intratumoral and peritumoral radiomics features combined with clinical and imaging indicators},
journal = {Frontiers in Oncology},
year = {2025},
volume = {15},
doi = {10.3389/fonc.2025.1531553}
}
EUVIMED